The result of a basic research to confirm KORTUC’s mechanism of tumor reoxygenation was presented at ESTRO (The European SocieTy for Radiotherapy and Oncology, Spain Madrid) by Dr. Samantha Nimalasena from the Institute of Cancer Research, UK.
The result demonstrates KORTUC’s mode of action to deliver oxygen into the tumor and resolve hypoxia, as a novel radiosensitizer.
Further information can be found below